StockDriftsStockDriftsBukwang Pharmaceutical (003000) has 0 disclosed insider purchases and 0 disclosed disposals on record, filed by 0 distinct insiders. The earliest filing StockDrifts holds for Bukwang Pharmaceutical is dated 2025-06-16; the most recent is 2025-07-17. All of it is parsed from DART D001/D002 insider disclosures, the official disclosure system operated by the Financial Supervisory Service (Korea).
| Date | Type | Source | Insider | Position | Shares | Price at filing | Return | Value |
|---|---|---|---|---|---|---|---|---|
| 2025-07-17 | BUY | 유상신주취득 | 권순일 Soonil Kwon | Managing Director | 582 | ₩3,645 | +47.3% | ₩2M ($1K) |
| 2025-07-17 | BUY | 유상신주취득 | OCI홀딩스 OCI Holdings | - | 9.1M | ₩3,645 | +47.3% | ₩33.3B ($23.1M) |
| 2025-07-17 | SELL | 기타 | 권순일 Soonil Kwon | Managing Director | -582 | ₩3,645 | -47.3% | ₩2M ($1K) |
| 2025-07-17 | SELL | 기타 | OCI홀딩스 OCI Holdings | - | -7.6M | ₩3,645 | -47.3% | ₩27.6B ($19.1M) |
| 2025-06-30 | SELL | 장외매도 | 김동연 Kim Dong-yeon | - | -2.5M | ₩3,670 | -46.3% | ₩9.1B ($6.3M) |
| 2025-06-30 | SELL | 장외매도 | 정창수 Changsoo Jeong | vice president | -2.1M | ₩3,670 | -46.3% | ₩7.8B ($5.4M) |
| 2025-06-30 | BUY | 장외매수 | OCI홀딩스 OCI Holdings | - | 4.8M | ₩3,670 | +46.3% | ₩17.7B ($12.3M) |
| 2025-06-16 | BUY | 기타 | 김동연 Kim Dong-yeon | - | 2.5M | ₩3,950 | +36.0% | ₩9.8B ($6.8M) |
| 2025-06-16 | BUY | 기타 | OCI홀딩스 OCI Holdings | - | 2.7M | ₩3,950 | +36.0% | ₩10.8B ($7.5M) |
| 2025-06-16 | BUY | 기타 | 권순일 Soonil Kwon | Managing Director | 582 | ₩3,950 | +36.0% | ₩2M ($2K) |
| 2025-06-16 | BUY | 기타 | 정창수 Changsoo Jeong | vice president | 2.1M | ₩3,950 | +36.0% | ₩8.4B ($5.9M) |
Every trade listed above is disclosed in DART D001/D002 insider disclosures, filed with the Financial Supervisory Service (Korea). View the original DART filings for Bukwang Pharmaceutical. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.